Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

4.145 +0.025 (+0.61%)

Streaming Delayed Price Updated: 10:59 AM EST, Feb 23, 2026 Add to My Watchlist

Price and Volume

Volume	130,259
Open	4.090
Bid (Size)	4.140 (300)
Ask (Size)	4.150 (600)
Prev. Close	4.120
Today's Range	4.070 - 4.160
52wk Range	2.860 - 13.99
Shares Outstanding	89,348,107
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Anavex (AVXL) Q1 2026 Earnings Call Transcript ↗

February 09, 2026

Anavex (AVXL) Q1 2026 Earnings Call Transcript

Via The Motley Fool

ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) Reports Q1 2026 Earnings Beat, Stock Gains in Pre-Market ↗

February 09, 2026

Via Chartmill

Performance

YTD	+12.6%	+12.6%
1 Month	-21.2%	-21.2%
3 Month	+34.6%	+34.6%
6 Month	-55.9%	-55.9%
1 Year	-49.8%	-49.8%

More News

These stocks are moving in today's after hours session ↗

January 13, 2026

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anavex Life Sciences Corp. – AVXL

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee ↗

November 10, 2025

Via Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

December 24, 2025

From Schall Law

Via GlobeNewswire

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

December 17, 2025

From Schall Law

Via GlobeNewswire

Anavex Stock Slides After Hours On EMA Panel’s Negative Alzheimer’s Drug Opinion — Retail Traders Talk Buyout Potential ↗

December 12, 2025

Via Stocktwits

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

December 10, 2025

From Schall Law

Via GlobeNewswire

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

December 03, 2025

From The Schall Law Firm

Via Business Wire

Anavex (AVXL) Q4 2025 Earnings Call Transcript ↗

November 25, 2025

Via The Motley Fool

AVXL Stock Jumps On Lower Q4 Loss, Anticipation For EMA Approval Of Alzheimer’s Drug ↗

November 25, 2025

Via Stocktwits

Anavex Life Sciences Corp (NASDAQ:AVXL) Surges on Better-Than-Expected Q4 2025 Earnings ↗

November 25, 2025

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

November 19, 2025

From Pomerantz LLP

Via GlobeNewswire

Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign' ↗

November 16, 2025

Via Stocktwits

Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗

November 14, 2025

Via Chartmill

Which stocks are moving on Friday? ↗

November 14, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 14, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 14, 2025

Via Chartmill

Discover the top movers in Friday's pre-market session. ↗

November 14, 2025

Via Chartmill

Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 14, 2025

Via Benzinga

AVXL Shares Slump Pre-market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug ↗

November 14, 2025

Via Stocktwits

Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug? ↗

November 14, 2025

Via Stocktwits

Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group ↗

October 29, 2025

Via Benzinga

Frequently Asked Questions

Is Anavex Life Sciences Corp. - Common Stock publicly traded?

Yes, Anavex Life Sciences Corp. - Common Stock is publicly traded.

What exchange does Anavex Life Sciences Corp. - Common Stock trade on?

Anavex Life Sciences Corp. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Anavex Life Sciences Corp. - Common Stock?

The ticker symbol for Anavex Life Sciences Corp. - Common Stock is AVXL on the Nasdaq Stock Market

What is the current price of Anavex Life Sciences Corp. - Common Stock?

The current price of Anavex Life Sciences Corp. - Common Stock is 4.145

When was Anavex Life Sciences Corp. - Common Stock last traded?

The last trade of Anavex Life Sciences Corp. - Common Stock was at 02/23/26 10:59 AM ET

What is the market capitalization of Anavex Life Sciences Corp. - Common Stock?

The market capitalization of Anavex Life Sciences Corp. - Common Stock is 370.35M

How many shares of Anavex Life Sciences Corp. - Common Stock are outstanding?

Anavex Life Sciences Corp. - Common Stock has 370M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.